News

The company said the Virginia facility "would be AstraZeneca’s largest single manufacturing investment in the world." The ...
Sen. Tim Kaine has been involved with bringing pharmaceutical reseach and development to central Virginia since his days on ...
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...
The deal, which Youngkin signed on Monday, has not been reviewed by the Democrat-controlled General Assembly. The governor ...
On July 21, AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to ...
The pharma sees the drug, gefurulimab, as a more convenient, self-administered alternative to the infused medicines it sells ...